Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Ranked by Number of employees in Georgia dedicated to FinTech Showcase your company news with guaranteed exposure both in print and online Innovation Awards will honor individuals, teams and ...

However, if blood sugar stays high over time, the lens converts the glucose into sorbitol. As sorbitol collects in the lens, it affects cells and proteins. These changes lead to cataracts and blurry ...